216 related articles for article (PubMed ID: 20736455)
1. Protease-activated receptors mediate crosstalk between coagulation and fibrinolysis.
McEachron TA; Pawlinski R; Richards KL; Church FC; Mackman N
Blood; 2010 Dec; 116(23):5037-44. PubMed ID: 20736455
[TBL] [Abstract][Full Text] [Related]
2. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
3. Regulation of thrombin-induced plasminogen activator inhibitor-1 in 4T1 murine breast cancer cells.
McEachron TA; Church FC; Mackman N
Blood Coagul Fibrinolysis; 2011 Oct; 22(7):576-82. PubMed ID: 21799402
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic characteristics of extracellular vesicles derived from prostate cancer cells.
Al Saleh HA; Haas-Neill S; Al-Hashimi A; Kapoor A; Shayegan B; Austin RC; Al-Nedawi K
Prostate; 2018 Sep; 78(13):953-961. PubMed ID: 29761522
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover.
Dong Z; Saliganan AD; Meng H; Nabha SM; Sabbota AL; Sheng S; Bonfil RD; Cher ML
Neoplasia; 2008 May; 10(5):439-49. PubMed ID: 18472961
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolysis protease receptors promote activation of astrocytes to express pro-inflammatory cytokines.
Pontecorvi P; Banki MA; Zampieri C; Zalfa C; Azmoon P; Kounnas MZ; Marchese C; Gonias SL; Mantuano E
J Neuroinflammation; 2019 Dec; 16(1):257. PubMed ID: 31810478
[TBL] [Abstract][Full Text] [Related]
7. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
[TBL] [Abstract][Full Text] [Related]
8. Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy: the role of coagulation and fibrinolysis in renal graft fibrosis.
Grandaliano G; Di Paolo S; Monno R; Stallone G; Ranieri E; Pontrelli P; Gesualdo L; Schena FP
Transplantation; 2001 Oct; 72(8):1437-43. PubMed ID: 11685117
[TBL] [Abstract][Full Text] [Related]
9. Protease-activated receptor-2 expression in IgA nephropathy: a potential role in the pathogenesis of interstitial fibrosis.
Grandaliano G; Pontrelli P; Cerullo G; Monno R; Ranieri E; Ursi M; Loverre A; Gesualdo L; Schena FP
J Am Soc Nephrol; 2003 Aug; 14(8):2072-83. PubMed ID: 12874461
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic regulation in human endothelial cells by fibrinolytic factors.
Fukao H; Matsuo O
Semin Thromb Hemost; 2000; 26(1):33-8. PubMed ID: 10805279
[TBL] [Abstract][Full Text] [Related]
11. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro.
Tanaka A; Suzuki Y; Sugihara K; Kanayama N; Urano T
Life Sci; 2009 Jul; 85(5-6):220-5. PubMed ID: 19500599
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.
Bryan L; Paugh BS; Kapitonov D; Wilczynska KM; Alvarez SM; Singh SK; Milstien S; Spiegel S; Kordula T
Mol Cancer Res; 2008 Sep; 6(9):1469-77. PubMed ID: 18819934
[TBL] [Abstract][Full Text] [Related]
14. Fibrin γ/γ' influences the secretion of fibrinolytic components and clot structure.
Cantero M; Rojas H; Anglés-Cano E; Marchi R
BMC Mol Cell Biol; 2019 Nov; 20(1):47. PubMed ID: 31675913
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid synovial fibroblasts constitutively express the fibrinolytic pattern of invasive tumor-like cells.
Guiducci S; Del Rosso A; Cinelli M; Margheri F; D'Alessio S; Fibbi G; Matucci Cerinic M; Del Rosso M
Clin Exp Rheumatol; 2005; 23(3):364-72. PubMed ID: 15971425
[TBL] [Abstract][Full Text] [Related]
16. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
Lockwood CJ; Krikun G; Aigner S; Schatz F
J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
[TBL] [Abstract][Full Text] [Related]
17. Activated platelets increase fibrinolysis of mesenchymal progenitor cells.
Agis H; Kandler B; Fischer MB; Watzek G; Gruber R
J Orthop Res; 2009 Jul; 27(7):972-80. PubMed ID: 19030175
[TBL] [Abstract][Full Text] [Related]
18. Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor.
Zheng Q; Tang ZY; Xue Q; Shi DR; Song HY; Tang HB
J Cancer Res Clin Oncol; 2000 Nov; 126(11):641-6. PubMed ID: 11079728
[TBL] [Abstract][Full Text] [Related]
19. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
20. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
Kruithof EK; Mestries JC; Gascon MP; Ythier A
Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
